All In MedTech

Device Trial Radar · NCT07298499

Amplification and Tinnitus Masker Performance and Benefit for Adults With Hearing Loss and Tinnitus

Post-Market Clinical Follow-Up of Hearing Aids and Tinnitus Masker Technology

Last checked: Nov 20, 2026Latest source record: Dec 31, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

100

Planned (sponsor's estimate)

Start

Jul 7, 2025

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Starkey Laboratories, IncNot on our public-company list
Sponsor type
Industry
First posted
Dec 23, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a Post-Market Clinical Investigation whose primary purpose is to evaluate hearing aid amplification and tinnitus masker performance for individuals with hearing loss and tinnitus. There are two primary hypotheses that will be assessed in this study: The use of well-fit amplification alone improves participants' ability to hear and improves tinnitus symptoms as compared to unaided conditions. The use of well-fit amplification in conjunction with a tinnitus masker improves participants' ability to hear and improves tinnitus symptoms as compared to unaided conditions. Participants will be fit with hearing aids for 6 months and a tinnitus masker will be activated at the 3-month mark of the study. Outcome measures will evaluate device performance and participant benefit from the devices throughout the study duration.

Conditions

  • Hearing Aid
  • Tinnitus

Interventions

  • Hearing AidDevice

    Inclusion of hearing aid or not for listening

  • Tinnitus MaskerDevice

    Inclusion of tinnitus masker in device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Provision of adequate amplificationTime frame: The time frame of this data collection is at the hearing aid fitting which occurs at the initial fitting (Session 1, day 1). This will occur the first time the participant is seen for the study visits.

5 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Starkey Satellite Research Facility Affordable Hearing Centers 6821 W 120th Ave Ste 2H, Broomfield, CO 80020

    Broomfield, Colorado

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.